Slow P has been an acceptable form of oral phosphate therapy in a series of patients with a variety of bone disease. Therapeutic responses have been achieved in a number of patients without side effects together with minor elevation of the serum and urinary phosphate in the majority of patients. Some patients have continued with such supplements for several months which encourages an extended trial under more stringent conditions.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.